About Complement pharma

About company

Complement Pharma is a developer of monoclonal antibody intended to treat neurodegenerative and immune-mediated disorders. The company's monoclonal antibody targets the complement pathway in order to treat immune-mediated disorders, to accelerate nerve regeneration in neurological disorders and drug therapies for neurological disorders, enabling patients to get an early-stage drug that treats and meets the high unmet medical need.